Add to ORKGIntroduction: Oral immunosuppressive drugs are commonly used in the treatment of atopic dermatitis (AD). In patients with autoimmune- and rheumatic diseases, these drugs have been associated with lymphopenia. Lymphopenia is related to an increased risk of opportunistic infections. The incidence of lymphopenia in patients with AD treated with oral immunosuppressive drugs is yet unknown. Objective: To evaluate the occurrence of recurrent lymphopenia in patients with AD treated with oral immunosuppressive drugs and to make recommendations for screening in daily practice. Methods: Patients with recurrent lymphopenia (i.e. >5 times lymphocyte counts below 0.8 × 109/L) during treatment with oral immunosuppressive drugs were included from our immu...
Abstract Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the...
Copyright © 2012 Itsuro Kazama et al. This is an open access article distributed under the Creative ...
Background and objectives ANCA-associated vasculitis (AAV) is treated with potent immunosuppressive ...
Introduction: Oral immunosuppressive drugs are commonly used in the treatment of atopic dermatitis (...
There is a lack of information on the use oral immunosuppressive drugs in atopic dermatitis (AD) dai...
Systemic use of immunosuppressant agents increases the risk of lymphoma in transplantation. We perfo...
BACKGROUND: Oral immunosuppressive drugs are frequently prescribed in young women with atopic dermat...
Although atopic dermatitis (AD) is a very common skin disease, data on the percentage of patients wi...
There is uncertainty about the risk of developing nonmelanoma skin cancer (NMSC), including basal ce...
There is uncertainty about the risk of developing non-melanoma skin cancer (NMSC), including basal c...
The impact of new and emerging therapies on the microenvironment of primary cutaneous lymphomas (PCL...
BackgroundPatients with moderate-to-severe atopic dermatitis (AD) have increased infection risk, inc...
Atopic dermatitis (AD) is a complex skin disease frequently associated with other diseases of the at...
At the time of this study, prior to the introduction of biologics in the US, systemic therapies used...
Atopic dermatitis (AD) is a complex skin disease frequently associated with other diseases of the at...
Abstract Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the...
Copyright © 2012 Itsuro Kazama et al. This is an open access article distributed under the Creative ...
Background and objectives ANCA-associated vasculitis (AAV) is treated with potent immunosuppressive ...
Introduction: Oral immunosuppressive drugs are commonly used in the treatment of atopic dermatitis (...
There is a lack of information on the use oral immunosuppressive drugs in atopic dermatitis (AD) dai...
Systemic use of immunosuppressant agents increases the risk of lymphoma in transplantation. We perfo...
BACKGROUND: Oral immunosuppressive drugs are frequently prescribed in young women with atopic dermat...
Although atopic dermatitis (AD) is a very common skin disease, data on the percentage of patients wi...
There is uncertainty about the risk of developing nonmelanoma skin cancer (NMSC), including basal ce...
There is uncertainty about the risk of developing non-melanoma skin cancer (NMSC), including basal c...
The impact of new and emerging therapies on the microenvironment of primary cutaneous lymphomas (PCL...
BackgroundPatients with moderate-to-severe atopic dermatitis (AD) have increased infection risk, inc...
Atopic dermatitis (AD) is a complex skin disease frequently associated with other diseases of the at...
At the time of this study, prior to the introduction of biologics in the US, systemic therapies used...
Atopic dermatitis (AD) is a complex skin disease frequently associated with other diseases of the at...
Abstract Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the...
Copyright © 2012 Itsuro Kazama et al. This is an open access article distributed under the Creative ...
Background and objectives ANCA-associated vasculitis (AAV) is treated with potent immunosuppressive ...